118 related articles for article (PubMed ID: 38809107)
1. A gold nanocluster/MIL-100(Fe) bimodal nanovector for the therapy of inflammatory disease through attenuation of Toll-like receptor signaling.
Zhao H; Becharef S; Dumas E; Carn F; Patriarche G; Mura S; Gazeau F; Serre C; Steunou N
Nanoscale; 2024 Jun; 16(25):12037-12049. PubMed ID: 38809107
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical superparamagnetic metal-organic framework nanovectors as anti-inflammatory nanomedicines.
Zhao H; Sene S; Mielcarek AM; Miraux S; Menguy N; Ihiawakrim D; Ersen O; Péchoux C; Guillou N; Scola J; Grenèche JM; Nouar F; Mura S; Carn F; Gazeau F; Dumas E; Serre C; Steunou N
J Mater Chem B; 2023 Apr; 11(14):3195-3211. PubMed ID: 36951043
[TBL] [Abstract][Full Text] [Related]
3. Intracellular synthesis of gold nanoparticles by
Liu Y; Perumalsamy H; Kang CH; Kim SH; Hwang JS; Koh SC; Yi TH; Kim YJ
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):777-788. PubMed ID: 32308043
[TBL] [Abstract][Full Text] [Related]
4. Green synthesis of gold nanoparticles using
Liu Y; Kim S; Kim YJ; Perumalsamy H; Lee S; Hwang E; Yi TH
Int J Nanomedicine; 2019; 14():2945-2959. PubMed ID: 31114201
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of dehydrocostus lactone on the toll-like receptor signaling pathways.
Kim SY; Heo S; Kim SH; Kwon M; Sung NJ; Ryu AR; Lee MY; Park SA; Youn HS
Int Immunopharmacol; 2020 Jan; 78():106075. PubMed ID: 31812722
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional iron-based Metal-Organic framework as biodegradable nanozyme for microwave enhancing dynamic therapy.
Ma X; Ren X; Guo X; Fu C; Wu Q; Tan L; Li H; Zhang W; Chen X; Zhong H; Meng X
Biomaterials; 2019 Sep; 214():119223. PubMed ID: 31174065
[TBL] [Abstract][Full Text] [Related]
7. Isotrifoliol inhibits pro-inflammatory mediators by suppression of TLR/NF-κB and TLR/MAPK signaling in LPS-induced RAW264.7 cells.
Li H; Yoon JH; Won HJ; Ji HS; Yuk HJ; Park KH; Park HY; Jeong TS
Int Immunopharmacol; 2017 Apr; 45():110-119. PubMed ID: 28192731
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory properties of cilostazol: Its interruption of DNA binding activity of NF-κB from the Toll-like receptor signaling pathways.
Sakamoto T; Ohashi W; Tomita K; Hattori K; Matsuda N; Hattori Y
Int Immunopharmacol; 2018 Sep; 62():120-131. PubMed ID: 30005227
[TBL] [Abstract][Full Text] [Related]
9. Amino Acid-Dependent Attenuation of Toll-like Receptor Signaling by Peptide-Gold Nanoparticle Hybrids.
Yang H; Fung SY; Xu S; Sutherland DP; Kollmann TR; Liu M; Turvey SE
ACS Nano; 2015 Jul; 9(7):6774-84. PubMed ID: 26083966
[TBL] [Abstract][Full Text] [Related]
10. Sparassis crispa exerts anti-inflammatory activity via suppression of TLR-mediated NF-κB and MAPK signaling pathways in LPS-induced RAW264.7 macrophage cells.
Han JM; Lee EK; Gong SY; Sohng JK; Kang YJ; Jung HJ
J Ethnopharmacol; 2019 Mar; 231():10-18. PubMed ID: 30395976
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoflowers synthesized using Acanthopanacis cortex extract inhibit inflammatory mediators in LPS-induced RAW264.7 macrophages via NF-κB and AP-1 pathways.
Ahn S; Singh P; Jang M; Kim YJ; Castro-Aceituno V; Simu SY; Kim YJ; Yang DC
Colloids Surf B Biointerfaces; 2018 Feb; 162():398-404. PubMed ID: 29245117
[TBL] [Abstract][Full Text] [Related]
12. Chrysin Derivative CM1 and Exhibited Anti-Inflammatory Action by Upregulating Toll-Interacting Protein Expression in Lipopolysaccharide-Stimulated RAW264.7 Macrophage Cells.
Byun EB; Song HY; Kim WS; Han JM; Seo HS; Park WY; Kim K; Byun EH
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799689
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
[TBL] [Abstract][Full Text] [Related]
14. Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury.
Zhang DY; Tu T; Younis MR; Zhu KS; Liu H; Lei S; Qu J; Lin J; Huang P
Theranostics; 2021; 11(20):9904-9917. PubMed ID: 34815794
[No Abstract] [Full Text] [Related]
15. Polymer/Aptamer-Integrated Gold Nanoconstruct Suppresses the Inflammatory Process by Scavenging ROS and Capturing Pro-inflammatory Cytokine TNF-α.
Kim J; Park H; Saravanakumar G; Kim WJ
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9390-9401. PubMed ID: 33155813
[TBL] [Abstract][Full Text] [Related]
16. Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice.
Zhu S; Jiang X; Boudreau MD; Feng G; Miao Y; Dong S; Wu H; Zeng M; Yin JJ
J Nanobiotechnology; 2018 Nov; 16(1):86. PubMed ID: 30384844
[TBL] [Abstract][Full Text] [Related]
17. Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.
Yang H; Fung SY; Bao A; Li Q; Turvey SE
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28784964
[TBL] [Abstract][Full Text] [Related]
18. Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species.
Komatsu W; Kishi H; Yagasaki K; Ohhira S
Eur J Pharmacol; 2018 Aug; 833():411-424. PubMed ID: 29932926
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
[TBL] [Abstract][Full Text] [Related]
20. A Novel 1,8-Naphthyridine-2-Carboxamide Derivative Attenuates Inflammatory Responses and Cell Migration in LPS-Treated BV2 Cells via the Suppression of ROS Generation and TLR4/Myd88/NF-κB Signaling Pathway.
Nguyen PL; Bui BP; Lee H; Cho J
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
